semaglutide after breast cancer GLP-1 Receptor Agonists in Cancer: A New Frontier in Obesity and Prognosis Management Weight changes after breast cancer
Description
Expectations and Results from Semaglutide Treatment Your semaglutide journey typically begins with a low dose, adjusted upward as tolerated, under close provider supervision
(2020) support this concept 2
Emma Davies, RN, INP
Compounded GLP-1s are made by specialty pharmacies and are not FDA-approved
However, these often lessen over time
It depends on how your body responds to the medication and when you reach your weight-loss goals
